In a study of patients with rheumatoid arthritis (RA) and first degree relatives (FDRs) of patients with RA, 70% (14 of 20) and 25% (17 of 67), respectively, tested positive for anti-cyclic citrullinated peptide (anti-CCP) antibodies in their sputum, including some FDRs who were seronegative. In FDRs, elevated sputum levels of anti-CCP antibodies were associated with elevated numbers of macrophages and neutrophils and increased levels of neutrophil extracellular traps in the sputum.